from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0602c/tcrA

LFCtreatmentdescriptionclass of inhibitor

-0.921

Amikacinug/mL Amikacintranslation

-0.661

Cap5-10ug/mL Capreomycintranslation

-0.544

Rox10-50 ug/mL Roxithromycintranslation

-0.039

SM2-5 ug/mL Streptomycintranslation

-1.204

Tet5-10 ug/mL Tetracyclinetranslation

-1.641

Rif0.2-5ug/mL Rifampicintranscription

-0.286

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.380

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.527

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.396

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.206

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.296

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.977

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.228

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.251

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.007

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.129

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.881

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.286

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.928

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.590

KCN5-20 ug/mL Potassium cyaniderespiration

-1.377

NaN30.2-2 mM Sodium aziderespiration

0.297

Nigericin50 uM Nigericinrespiration

-0.610

TRC10-150 ug/mL Triclosanrespiration

-1.480

TRZ10-25 ug/mL Thioridazinerespiration

0.848

Valinomycin0.5-10 uM Valinomycinrespiration

1.280

ZnSO42 mM ZnSO4respiration

0.922

menadione6-10 ug/mL Menadionerespiration

0.141

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.625

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

1.443

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.774

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.874

NRP_1Non-replicating persistence stage 1dosRassociated

0.380

Amp0.2mg/mL AmpicillincellWall

-0.346

Cephalexin20-100 ug/mL CephalexincellWall

0.358

Cerulenin0.32-5 ug/mL CerulenincellWall

0.017

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.062

EMB10-20 ug/mL EthambutolcellWall

0.029

Eta12-40 ug/mL EthionamidecellWall

0.280

INH0.2-0.4 ug/mL IsoniazidcellWall

0.257

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.468

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.599

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.621

BZA0.12 mg/mL BenzamidearomaticAmides

-0.094

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.199

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.519

H2O24 mM hydrogen peroxideDNAdamaging

0.147

Levo10 ug/mL LevofloxacinDNAdamaging

0.273

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.313

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.275

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.103

UVUV-irradiationDNAdamaging

0.165

ARP41-4 ug/mL Antitubercular compound ARP4?

0.741

Antimycin12.5-50 ug/mL Antimycin A?

0.286

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.562

PA_110-50 ug/mL Antitubercular compound PA-1?

0.038

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.734

PA8240.2-2 ug/mL PA-824?

-1.286

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.012

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.502

Verapamil50 uM Verapamil?

0.598

mercaptoethanol2 mM 2-Mercaptoethanol?

0.922

methoxatin10-20 ug/mL Methoxatin?